2026 Angus G. Dalgleish: Immunology Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Immunology	71	2277	2092	204	197	387	25810

Overview

Angus G. Dalgleish is affiliated with St George's, University of London in the United Kingdom. Their research primarily spans the fields of Medicine and Immunology and Microbiology, with a significant focus on oncology and immunology subfields. They have contributed to the study of Oncology, Immunology, Molecular Biology, Infectious Diseases, and Cancer Research.

Their main research topics include:

Immunotherapy and Immune Responses
Cancer Immunotherapy and Biomarkers
Pancreatic and Hepatic Oncology Research
Immune Cell Function and Interaction
CAR-T cell therapy research
SARS-CoV-2 and COVID-19 Research
Monoclonal and Polyclonal Antibodies Research

Dalgleish has published multiple papers across well-known venues. Frequent publication venues include:

Oncology Reports
Frontiers in Immunology
Oncology Letters
Cancer Research
Journal for ImmunoTherapy of Cancer

Selected recent papers authored or co-authored by Dalgleish include:

Results of a randomized, double-blind phase II clinical trial of NY-ESO-1 vaccine with ISCOMATRIX adjuvant versus ISCOMATRIX alone in participants with high-risk resected melanoma, 2020, Journal for ImmunoTherapy of Cancer
Biovacc-19: A Candidate Vaccine for Covid-19 (SARS-CoV-2) Developed from Analysis of its General Method of Action for Infectivity, 2020, QRB Discovery
Mitigating Coronavirus Induced Dysfunctional Immunity for At-Risk Populations in COVID-19: Trained Immunity, BCG and "New Old Friends", 2020, Frontiers in Immunology
Directing T-Cell Immune Responses for Cancer Vaccination and Immunotherapy, 2021, Vaccines
Effect of Gemcitabine based chemotherapy on the immunogenicity of pancreatic tumour cells and T-cells, 2020, Clinical & Translational Oncology

Among frequent collaborators, Dalgleish has worked extensively with Satvinder Mudan, Helmout Modjtahedi, Peter L. Smith, Alan M. Seddon, and Said Khelwatty. Collaboration with these researchers is demonstrated by multiple joint publications.

Best Publications

The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus

Angus G. Dalgleish;Peter C. L. Beverley;Paul R. Clapham;Dorothy H. Crawford

5059
Citations
The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain.

Paul Jay Maddon;Angus G. Dalgleish;J.Steven McDougal;Paul R. Clapham

2848
Citations
The evolution of thalidomide and its IMiD derivatives as anticancer agents

J. Blake Bartlett;Keith Dredge;Angus G. Dalgleish

1177
Citations
Slim disease: a new disease in Uganda and its association with HTLV-III infection.

D. Serwadda;N.K. Sewankambo;J.W. Carswell;A.C. Bayley

848
Citations
Chronic immune activation and inflammation as the cause of malignancy.

Kenneth J. O'Byrne;A. G. Dalgleish

740
Citations
Neutralization of human T-lymphotropic virus type III by sera of AIDS and AIDS-risk patients.

Robin A. Weiss;Paul R. Clapham;Rachanee Cheingsong-Popov;Angus G. Dalgleish

611
Citations
Soluble CD4 blocks the infectivity of diverse strains of HIV and SIV for T cells and monocytes but not for brain and muscle cells

Paul R. Clapham;Jonathan N. Weber;Denise Whitby;Kenneth McIntosh;Kenneth McIntosh

517
Citations
Epitopes of the CD4 antigen and HIV infection.

Quentin J. Sattentau;Angus G. Dalgleish;Robin A. Weiss;Peter C. L. Beverley

501
Citations
Novel thalidomide analogues display anti-angiogenic activity independently of immunomodulatory effects

Dredge K;Marriott Jb;Macdonald Cd;Man Hw

496
Citations
The use of 7-amino actinomycin D in identifying apoptosis : Simplicity of use and broad spectrum of application compared with other techniques

N. J. Philpott;A. J. C. Turner;J. Scopes;M. Westby

476
Citations
The anti-cancer agents lenalidomide and pomalidomide inhibit the proliferation and function of T regulatory cells

Christine Galustian;Brendan Meyer;Marie-Christine Labarthe;Keith Dredge

469
Citations
Variable and conserved neutralization antigens of human immunodeficiency virus

Robin A. Weiss;Paul R. Clapham;Jonathan N. Weber;Angus G. Dalgleish

392
Citations
Orally administered lenalidomide (CC-5013) is anti-angiogenic in vivo and inhibits endothelial cell migration and Akt phosphorylation in vitro.

Keith Dredge;Rebecca Horsfall;Simon P. Robinson;Ling-Hua Zhang

372
Citations
Pre-treatment with chemotherapy can enhance the antigenicity and immunogenicity of tumours by promoting adaptive immune responses

Unknown

358
Citations
Origins of HIV and the evolution of resistance to AIDS.

Jonathan L. Heeney;Angus G. Dalgleish;Robin A. Weiss

321
Citations
HIV infection does not require endocytosis of its receptor, CD4.

Paul Jay Maddon;J. Steven McDougal;Paul R. Clapham;Angus G. Dalgleish

314
Citations
Phase I Study of an Immunomodulatory Thalidomide Analog, CC-4047, in Relapsed or Refractory Multiple Myeloma

Unknown

313
Citations
PREVALENCE OF ANTIBODY TO HUMAN T-LYMPHOTROPIC VIRUS TYPE III IN AIDS AND AIDS-RISK PATIENTS IN BRITAIN

R Cheingsong-Popov;R.A Weiss;A Dalgleish;R.S Tedder

280
Citations
The relationship between angiogenesis and the immune response in carcinogenesis and the progression of malignant disease.

Kenneth J. O'Byrne;A. G. Dalgleish;M. J. Browning;W. P. Steward

274
Citations
Phase I study to determine the safety, tolerability and immunostimulatory activity of thalidomide analogue CC-5013 in patients with metastatic malignant melanoma and other advanced cancers

J B Bartlett;A Michael;I A Clarke;K Dredge

250
Citations
Chronic immune activation and inflammation in the pathogenesis of AIDS and cancer.

Angus G Dalgleish;Ken J O'Byrne

227
Citations
Human immunodeficiency virus infection of monocytic and T-lymphocytic cells: receptor modulation and differentiation induced by phorbol ester.

Paul R. Clapham;Robin A. Weiss;Angus G. Dalgleish;Mark Exley

221
Citations
Protective Antitumor Immunity Induced by a Costimulatory Thalidomide Analog in Conjunction with Whole Tumor Cell Vaccination Is Mediated by Increased Th1-Type Immunity

Keith Dredge;J. Blake Marriott;Stephen M. Todryk;George W. Muller

219
Citations

Frequent Co-Authors

Stephen Todryk Northumbria University

Kenneth J. O'Byrne Queensland University of Technology

Paul R. Clapham University of Massachusetts Chan Medical School

William P. Steward University of Leicester

Peter Smith University of Aberdeen

Mark R. Middleton University of Oxford

Christian H. Ottensmeier University of Southampton

Robin A. Weiss University College London

Jonathan L. Heeney University of Cambridge

Paul Lorigan University of Manchester

External Links

Wikipedia of Angus G. Dalgleish Personal website of Angus G. Dalgleish

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

For those interested in Immunology, pursuing related degrees such as nursing can open diverse career pathways. Many students look for the easiest nurse practitioner program to balance rigorous study with personal commitments, ensuring a smoother transition into healthcare roles.

Specializations like psychiatric nursing are also popular, with some of the best psychiatric mental health nurse practitioner programs online offering strong clinical placement rates that provide invaluable hands-on experience for future practitioners.

Cost is a significant consideration for many students. Fortunately, several affordable options exist; exploring cheap psych np programs can help reduce financial barriers while still offering quality education and career readiness.

Graduates pursuing advanced nursing degrees like the Doctor of Nursing Practice (DNP) often benefit from competitive salaries. Understanding the doctor of nursing practice salary by state can guide career decisions and geographic preferences for employment.